Viewing Study NCT06534892


Ignite Creation Date: 2025-12-24 @ 3:27 PM
Ignite Modification Date: 2025-12-26 @ 5:45 AM
Study NCT ID: NCT06534892
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-22
First Post: 2024-07-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module